Universidad Peruana Cayetano Heredia
Global surveillance, research, and collaboration needed to improve understanding and management of long COVID
JavaScript is disabled for your browser. Some features of this site may not work without it.
Mostrar el registro sencillo del ítem
| dc.contributor.author | Ward, Helen | |
| dc.contributor.author | Flower, Barnaby | |
| dc.contributor.author | Garcia Funegra, Patricia Jannet | |
| dc.contributor.author | Xiang Ong, Sean Wei | |
| dc.contributor.author | Altmann, Daniel M. | |
| dc.contributor.author | Delaney, Brendan | |
| dc.contributor.author | Smith, Nikki | |
| dc.contributor.author | Elliott, Paul | |
| dc.contributor.author | Cooke, Graham. | |
| dc.date.accessioned | 2022-02-17T19:23:14Z | |
| dc.date.available | 2022-02-17T19:23:14Z | |
| dc.date.issued | 2021 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12866/11400 | |
| dc.description.abstract | The scale of chronic ill health and disability after COVID-19 has been described as the next big global health challenge.1 Prevalence estimates of a post-COVID-19 condition, long COVID, or post-acute sequelae of SARS-CoV-2 vary according to definition, methodology, and population. A recent systematic review reported persistent symptoms at 3–6 months in a median of 57% (range 13–92) of hospitalised patients (six studies) and 26% (2–62) of non-hospitalised patients (ten studies).2 This study and other reviews identified few studies from low-income settings,3 but with more than 245 million SARS-CoV-2 infections reported globally,4 millions of people are likely to already be experiencing long-term illness. While COVID-19 vaccines have reduced the risk of severe COVID-19 and death, continued high rates of SARS-CoV-2 infection will lead to further disability, having a huge impact on individuals, their families, health services, and society... | en_US |
| dc.language.iso | eng | |
| dc.publisher | Elsevier | |
| dc.relation.ispartofseries | Lancet | |
| dc.rights | info:eu-repo/semantics/restrictedAccess | |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es | |
| dc.subject | Global surveillance | en_US |
| dc.subject | COVID-19 | en_US |
| dc.subject | management of COVID-19 | en_US |
| dc.title | Global surveillance, research, and collaboration needed to improve understanding and management of long COVID | en_US |
| dc.type | info:eu-repo/semantics/article | |
| dc.identifier.doi | https://doi.org/10.1016/S0140-6736(21)02444-2 | |
| dc.relation.issn | 1474-547X |
Ficheros en el ítem
| Ficheros | Tamaño | Formato | Ver |
|---|---|---|---|
|
No hay ficheros asociados a este ítem. |
|||
Este ítem aparece en la(s) siguiente(s) colección(ones)
-
Artículos en revistas indizadas [4989]
Recuperados de bases de datos bibliográficas
Excepto si se señala otra cosa, la licencia del ítem se describe como info:eu-repo/semantics/restrictedAccess
